Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Tamoxifen
Related studies linked through entity extraction aliases.
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial
- Status
- SUSPENDED
- Phase
- PHASE3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- Status
- RECRUITING
- Phase
- PHASE2
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- Status
- RECRUITING
- Phase
- PHASE2
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- Status
- RECRUITING
- Phase
- PHASE2
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- Status
- RECRUITING
- Phase
- PHASE3
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Roll-over Study to Allow Continued Access to Ribociclib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
- Status
- RECRUITING
- Phase
- PHASE2
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- Status
- RECRUITING
- Phase
- PHASE3
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2